Guardant Health, Inc. (GH)

Guardant Health Stock Forecast

Stock Price Forecast

The 20 analysts that cover Guardant Health stock have a consensus rating of "Strong Buy" and an average price target of $117.8, which forecasts a 27.72% increase in the stock price over the next year. The lowest target is $55 and the highest is $180.

Price Target: $117.8 (+27.72%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$55	$117.8	$130	$180
Change	-40.37%	+27.72%	+40.95%	+95.16%

Analyst Ratings

The average analyst rating for Guardant Health stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Sep '25	Oct '25	Nov '25	Dec '25	Jan '26	Feb '26
Strong Buy	7	8	8	8	8	7
Buy	14	15	15	13	12	12
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	21	23	23	21	21	20

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Westenberg Piper Sandler	Piper Sandler	Buy Maintains $120 → $130	Buy	Maintains	$120 → $130	+40.95%	Feb 24, 2026
Puneet Souda Leerink Partners	Leerink Partners	Buy Maintains $170 → $180	Buy	Maintains	$170 → $180	+95.16%	Feb 20, 2026
Patrick Donnelly Citigroup	Citigroup	Strong Buy Maintains $135 → $150	Strong Buy	Maintains	$135 → $150	+62.64%	Feb 20, 2026
Kyle Mikson Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $125 → $135	Strong Buy	Maintains	$125 → $135	+46.37%	Feb 20, 2026
Casey Woodring JP Morgan	JP Morgan	Buy Maintains $120 → $130	Buy	Maintains	$120 → $130	+40.95%	Feb 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

1.27B

Increased by 29.73%

from 982.02M

Revenue Next Year

1.63B

Increased by 27.71%

from 1.27B

EPS This Year

-2.51

from -3.32

EPS Next Year

-1.59

from -2.51

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	373.65M	449.54M	563.95M	739.02M	982.02M	1.27B	1.63B
Revenue Growth	30.32%	20.31%	25.45%	31.04%	32.88%	29.73%	27.71%
EPS	-4.00	-6.41	-4.28	-3.56	-3.32	-2.51	-1.59
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	28	25

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028	2029	2030
High	1.4B	2.0B
Avg	1.3B	1.6B
Low	1.1B	1.4B

Revenue Growth

Revenue Growth	2026	2027	2028	2029	2030
High	41.6%	55.3%
Avg	29.7%	27.7%
Low	16.0%	6.5%

EPS Forecast

EPS	2026	2027	2028	2029	2030
High	-1.73	-0.77
Avg	-2.51	-1.59
Low	-3.33	-2.57

EPS Growth

EPS Growth	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.